Source 1primary paper2025MED
Toolkit/single molecule array
single molecule array
Also known as: SIMOA
Taxonomy: Technique Branch / Method. Workflows sit above the mechanism and technique branches rather than replacing them.
Summary
Classical immunoassays such as enzyme-linked immunosorbent assay (ELISA), chemiluminescent enzyme immunoassay (CLEIA), and single molecule array (SIMOA) remain central to fluid based detection, offering high sensitivity and clinical validation.
Usefulness & Problems
Why this is useful
SIMOA is identified as a central fluid-based assay platform for p-Tau detection. The abstract frames it as part of the benchmark immunoassay toolkit.; fluid-based detection of hyperphosphorylated Tau
Source:
SIMOA is identified as a central fluid-based assay platform for p-Tau detection. The abstract frames it as part of the benchmark immunoassay toolkit.
Source:
fluid-based detection of hyperphosphorylated Tau
Problem solved
It supports highly sensitive and clinically validated p-Tau measurement for diagnosis and monitoring.; provides clinically validated p-Tau detection in fluids
Source:
It supports highly sensitive and clinically validated p-Tau measurement for diagnosis and monitoring.
Source:
provides clinically validated p-Tau detection in fluids
Problem links
provides clinically validated p-Tau detection in fluids
LiteratureIt supports highly sensitive and clinically validated p-Tau measurement for diagnosis and monitoring.
Source:
It supports highly sensitive and clinically validated p-Tau measurement for diagnosis and monitoring.
Taxonomy & Function
Primary hierarchy
Technique Branch
Method: A concrete measurement method used to characterize an engineered system.
Mechanisms
immunodetectionTechniques
Functional AssayTarget processes
No target processes tagged yet.
Implementation Constraints
cofactor dependency: cofactor requirement unknownencoding mode: genetically encodedimplementation constraint: context specific validationoperating role: sensor
The abstract supports use of a single-molecule array immunoassay platform in fluid samples, but does not specify hardware or reagents.; requires immunoassay platform for fluid-based detection
Independent follow-up evidence is still limited. Validation breadth across biological contexts is still narrow. Independent reuse still looks limited, so the evidence base may be fragile. No canonical validation observations are stored yet, so context-specific performance remains under-specified.
Validation
Cell-freeBacteriaMammalianMouseHumanTherapeuticIndep. Replication
Supporting Sources
Ranked Claims
ELISA, CLEIA, and SIMOA remain central to fluid-based p-Tau detection and offer high sensitivity and clinical validation.
Approval Evidence
1 source1 linked approval claimfirst-pass slug single-molecule-array
Classical immunoassays such as enzyme-linked immunosorbent assay (ELISA), chemiluminescent enzyme immunoassay (CLEIA), and single molecule array (SIMOA) remain central to fluid based detection, offering high sensitivity and clinical validation.
Source:
assay utilitysupports
ELISA, CLEIA, and SIMOA remain central to fluid-based p-Tau detection and offer high sensitivity and clinical validation.
Source:
Comparisons
Source-stated alternatives
The abstract lists ELISA and CLEIA as other classical immunoassays and contrasts all three with newer biosensor platforms.
Source:
The abstract lists ELISA and CLEIA as other classical immunoassays and contrasts all three with newer biosensor platforms.
Source-backed strengths
high sensitivity; clinical validation
Source:
high sensitivity
Source:
clinical validation
Compared with chemiluminescent enzyme immunoassay
The abstract lists ELISA and CLEIA as other classical immunoassays and contrasts all three with newer biosensor platforms.
Shared frame: source-stated alternative in extracted literature
Strengths here: high sensitivity; clinical validation.
Source:
The abstract lists ELISA and CLEIA as other classical immunoassays and contrasts all three with newer biosensor platforms.
Compared with enzyme-linked immunosorbent assay
The abstract lists ELISA and CLEIA as other classical immunoassays and contrasts all three with newer biosensor platforms.
Shared frame: source-stated alternative in extracted literature
Strengths here: high sensitivity; clinical validation.
Source:
The abstract lists ELISA and CLEIA as other classical immunoassays and contrasts all three with newer biosensor platforms.
Ranked Citations
- 1.